About Santhera
Santhera Pharmaceutical Holding Ltd

About Santhera

Executive Management

Klaus Schollmeier has been Chief Executive Officer since the Company’s inception in 2004. Before joining Santhera, he served for 16 years in senior business and scientific management positions in the pharmaceutical industry. Mr Schollmeier holds a PhD in biology from the University of Düsseldorf. Read more...

Barbara Heller has been Chief Financial Officer since 2005. Previously she worked for 15 years in senior management positions in investment and corporate banking. Mrs Heller holds a master in economics from the University of Zurich. Read more...

Helmut Kessmann has been Chief Business Officer since 2004. Before joining the Company, he served for 14 years in senior scientific, business development and management positions of biotech and life science companies. Mr Kessmann holds a PhD in biochemistry from the University of Münster. Read more...

Thomas Meier has been Chief Scientific Officer since 2004. He was founder and CEO of MyoContract, one of Santhera’s predecessor companies. Mr Meier holds a PhD in biology from the University of Basel. Read more...